ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 1912 • 2012 ACR/ARHP Annual Meeting

    Colchicine, As Assessed by Target Joint Pain Scores, Is Effective At 16 Hours in Patients with Acute Gout Flares

    Suman Wason1, Thomas Lauterio1, Steve Crockett1 and Matthew W. Davis2, 1Clinical Development, URL Pharma, Philadelphia, PA, 2Clinical Pharmacology, URL Pharma, Philadelphia, PA

    Background/Purpose: The management of patients with gout remains suboptimal, leading to increasing frequency and severity of recurrent flares that eventually lead to joint destruction and…
  • Abstract Number: 1913 • 2012 ACR/ARHP Annual Meeting

    Complete Tophus Response in Patients with Chronic Gout Initiating Pegloticase Treatment

    Michael A. Becker1, Neil J. Gonter2, Janet E. Pope3, Raymond L. Malamet4 and Herbert S. B. Baraf5, 1Medicine, University of Chicago, Chicago, IL, 2Rheumatology Associates of North Jersey, Teaneck, NJ, 3Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 4Global Medical Affairs, Savient Pharmaceuticals, Inc., Bridgewater, NJ, 5Arthritis & Rheumatism Associates, Wheaton, MD

    Background/Purpose: Pegloticase, a recombinant modified mammalian uricase that acts via enzymatic degradation of uric acid to allantoin, is approved in the US for the treatment…
  • Abstract Number: 1914 • 2012 ACR/ARHP Annual Meeting

    The Diagnosis and Management of Gout in 2012: Survey of US and Canadian Rheumatologists

    John J. Cush1 and Robert T. Keenan2, 1Baylor Research Institute, Dallas, TX, 2Rheumatology, Duke University, Durham, NC

    Background/Purpose: The introduction of novel treatment modalities for gout has escalated interest and education on this topic.  Although gout is the most common inflammatory arthropathy…
  • Abstract Number: 1915 • 2012 ACR/ARHP Annual Meeting

    Elevated Serum Homocysteine Levels Were Related Not with Serum Uric Acid Levels but with Decreased Renal Function in Chronic Gouty Patients

    Sang Tae Choi1, Jung-Soo Song1, Jin Su Kim2, Eun-Jin Kang3, Kwang-Hoon Lee4 and You-Jung Ha5, 1Rheumatology, Chung-Ang University College of Medicine, Seoul, South Korea, 2Chung-Ang University College of Medicine, Seoul, South Korea, 3Rheumatology, Busan Medical Center, Busan, South Korea, 4Dongguk University Ilsan Hospital, Goyang, South Korea, 5Kwandong University college of Medicine, Goyang, South Korea

    Background/Purpose: Hyperhomocysteinemia, which is related with cardiovascular diseases and metabolic syndrome, is regarded as one of the important factors in endothelial cell damage processes. It…
  • Abstract Number: 1916 • 2012 ACR/ARHP Annual Meeting

    Serum Uric Acid As a Biomarker for Mitigation of Infusion Reactions in Patients Treated with Pegloticase for Refractory Chronic Gout

    Herbert S. B. Baraf1, Robert A. Yood2, John S. Sundy3, Faith D. Ottery4 and Michael A. Becker5, 1Arthritis & Rheumatism Associates, Wheaton, MD, 2Reliant Medical Group, Worcester, MA, 3Duke Clinical Research Institute, Duke University Medical Center, Durham, NC, 4Medical Affairs, Savient Pharmaceuticals, Inc., East Brunswick, NJ, 5Medicine, University of Chicago, Chicago, IL

    Background/Purpose: Using data pooled from the randomized, placebo-controlled trials (RCTs) of pegloticase, post-hoc analyses of urate-lowering, antibody titers and the patterns of infusion-related reactions (IRs)…
  • Abstract Number: 1917 • 2012 ACR/ARHP Annual Meeting

    Long-Term Follow-up of IgG4-Related Diseases Presenting with Lacrimal and Salivary Gland Involvement

    Hiroki Takahashi1, Motohisa Yamamoto1, Tetsuya Tabeya1, Chisako Suzuki1, Yasuyoshi Naishiro1, Yasuhisa Shinomura1 and Kohzoh Imai2, 1First Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan, 2The Institute of Medical Science, The University of Tokyo, Tokyo, Japan

    Background/Purpose: IgG4-related disease (IgG4-RD) is a recently recognized disease entity that is characterized by tumefactive and hyperplastic lesions in various organs including the lacrimal and…
  • Abstract Number: 1918 • 2012 ACR/ARHP Annual Meeting

    Cluster Analysis of Organ Involvements Patients with Serum IgG4 Elevation; IgG4–related Disease Is a Distinct Subtype of Patients with Hyper-IgG4

    Masamitsu Tatewaki, Kazuhiro Kurasawa, Ayae Tanaka, Junya Nagasawa, Satoko Arai, Reika Maezawa, Takayoshi Owada and Takeshi Fukuda, Clinical Immunology, Dokkyo Medical University, Mibu, Tochigi, Japan

    Background/Purpose:   IgG4-related disease (IgG4-RD) is a multi-organ affecting disease characterized by fibroinflammatory lesions with a abundant IgG4-positive plasma cells infiltration. This disorder includes many…
  • Abstract Number: 1879 • 2012 ACR/ARHP Annual Meeting

    Work Related Injuries Causing or Aggravating Fibromyalgia in the Medicolegal Arena: A Jurisprudential Analysis

    Mary-Ann Fitzcharles1, Peter A. Ste-Marie2 and Yoram Shir3, 1Rheumatology and Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada, 2University of Montreal, Montreal, QC, Canada, 3Alan Edwards Pain Management Unit, McGill University Health Centre, Montreal, QC, Canada

    Background/Purpose: Up to 40% of persons report onset of fibromyalgia (FM) following a “triggering event”. Injuries, which may occur in the workplace, may be implicated…
  • Abstract Number: 1880 • 2012 ACR/ARHP Annual Meeting

    A Brazilian Portuguese Validation of the Revised Fibromyalgia Impact Questionnaire (FIQR)

    Eduardo S. Paiva1, Roberto E. Heymann2, Marcelo C. Rezende3, Milton Helfenstein Jr.4, José E. Martinez5, José R. Provenza6, Aline Ranzolin7, Marcos Renato Assis8, Vivian D. Pasqualin9 and Robert M. Bennett10, 1Rheumatology, Universidade Federal do Paraná, Curitiba, Brazil, 2Rheumatology, Universidade Federal de São Paulo, São Paulo, Brazil, 3Rheumatology, Santa Casa de Campo Grande, Campo Grande, Brazil, 4Rheumatology, Universidade Federal de de São Paulo, São Paulo, Brazil, 5Rheumatology, Pontifícia Universidade Católica de São Paulo, Sorocaba, Brazil, 6Rheumatology, Pontifícia Universidade Católica de Campinas, Campinas, Brazil, 7Universidade Federal de Pernambuco, Recife PE, Brazil, 8Faculdade de Medicina de Marilia, Marilia, Brazil, 9Pontifícia Universidade Católica do Paraná, Curitiba, Brazil, 10Medicine & Nursing, Oregon Health & Science Univ, Portland, OR

    Background/Purpose: General health evaluation questionnaires are important instruments in assessing the impact of disorders that affect multiple domains of a patient´s life. The Fibromyalgia Impact Questionnaire…
  • Abstract Number: 1881 • 2012 ACR/ARHP Annual Meeting

    Increased Psychosocial Stress Is a Major Component of Fibromyalgia Triggers

    Emma K. Guymer1, Kathleen Elford2 and Geoffrey O. Littlejohn3, 1Rheumatology and Medicine, Monash Medical Centre and Monash University, Clayton, Victoria, Australia, 2Rheumatology, Monash Medical Centre, Clayton, Victoria, Australia, 3Rheumatology, Monash Medical Centre and Monash University, Clayton, VIC, Australia

    Background/Purpose: Fibromyalgia is a common, chronic pain disorder. Initial development of symptoms occurs under conditions unique to each patient.  Psychological and physical triggers are recognized,…
  • Abstract Number: 1882 • 2012 ACR/ARHP Annual Meeting

    Predictors of a Favorable Outcome in Patients with Fibromyalgia: Results From the 1-Year Follow-up

    Dong-Jin Park1, Shin-Seok Lee2, Seong-Ho Kim3, Seong-Su Nah4, Ji Hyun Lee5, Seong-Kyu Kim6, Yeon-Ah Lee7, Seung-Jae Hong7, Hyun-Sook Kim8, Hye-Soon Lee9, Hyoun Ah Kim10, Chung-Il Joung11 and Sang-Hyon Kim12, 1Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 2Dept of Int Med/Rheumatology, Chonnam National University Medical School, Gwangju, South Korea, 3Department of Internal Medicine,, Inje University Haeundae Paik Hospital, Busan, South Korea, 4Rheumatology, Soonchunhyang University, South Korea, 5Division of Rheumatology, Department of Internal Medicine, Maryknoll Medical Center, Busan, South Korea, 6Catholic University of Daegu School of Medicine, Daegu, South Korea, 7Division of Rheumatology, Department of Internal Medicine, Kyung Hee University, Seoul, South Korea, 8Internal Medicine, Chosun University Hospital, Gwangju, South Korea, 9Department of Rheumatology, Hanyang University Guri Hospital, Guri, South Korea, 10Ajou University Hospital, Suwon, South Korea, 11Department of Internal Medicine, Konyang university hospital, Daejeon, South Korea, 12Division of Rheumatology, Department of Internal Medicine, Keimyung University School of Medicine, Daegu, South Korea

    Background/Purpose: To determine the outcomes in Korean patients with fibromyalgia (FM) and identify the prognostic factors associated with improvement at 1-year follow-up. Methods: Forty-eight patients…
  • Abstract Number: 1883 • 2012 ACR/ARHP Annual Meeting

    Efficacy and Safety of Joint and Soft Tissue Injections; A Retrospective Study

    Jenny Cabas-Vargas1, Leah Alon2, Nina Ramessar2, Dimitre Stefanov2, Jose B. Toro and Deana M. Lazaro4, 1Rheumatology, SUNY Downstate, Brooklyn, NY, 2Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY, 3Medical Service (111), Brooklyn VA, Brooklyn, NY

    Background/Purpose: Despite wide use of corticosteroid injection in the treatment of soft tissue and articular disorders, there is little data about its efficacy.  We conducted…
  • Abstract Number: 1884 • 2012 ACR/ARHP Annual Meeting

    Fibromyalgia Patients Who Meet the ACR 1990 Criteria Have More Severe Disease

    Carmen E. Gota1, Benjamin Nutter2 and William Wilke3, 1The Cleveland Clinic Rheum, The Cleveland Clinic Desk A50, Cleveland, OH, 2Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, 3Rheumatology & Immunology, Cleveland Clinic Foundation, Cleveland, OH

    Background/Purpose: To compare the fibromyalgia patients who meet the 1990 ACR criteria for fibromyalgia with those who do not. Methods: All new consecutive patients diagnosed…
  • Abstract Number: 1885 • 2012 ACR/ARHP Annual Meeting

    Rheumatologists’ Ultrasound Confidence and Interpretation of Normal Anatomy Are Improved by a Cadaver Based Sonoanatomy Course

    Iain Goff1, David Wright2 and Debra Patten3, 1Musculoskeletal Research Group, Newcastle University, Newcastle upon Tyne, United Kingdom, 2Rheumatology, Sunderland Royal Hospital, Sunderland, United Kingdom, 3The Medical School, University of Newcastle upon Tyne, School of Medical Sciences Education and Development, Newcastle upon Tyne, United Kingdom

    Background/Purpose: Correct interpretation of musculoskeletal ultrasound (MSUS) requires thorough knowledge of normal 3D anatomy, but several authors report deficiencies in anatomy skills among rheumatologists. Cadaver-based…
  • Abstract Number: 1886 • 2012 ACR/ARHP Annual Meeting

    Evaluation of a New Educational Tool: A Resident’s Guide to Pediatric Rheumatology

    Tania Cellucci1 and Ronald Laxer2, 1Pediatrics/Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 2Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada

    Background/Purpose:  “A Resident’s Guide to Pediatric Rheumatology” was specifically designed to address a gap in pediatric rheumatology teaching resources. It was intended for medical students…
  • « Previous Page
  • 1
  • …
  • 2475
  • 2476
  • 2477
  • 2478
  • 2479
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology